• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

HUMIRA

TNF inhibitors and the microbiome

August 24, 2018Autoimmune Diseases, Microbiome, Vizit Graphs
TNF inhibitors and the microbiome

Study microbiota of patients treated with TNF inhibitors with Biovista Vizit. Explore the live graph.

Vizit Graphs Tag Cloud

CLOSTRIDIUM DIFFICILE DOXORUBICIN CANCER TH17 CELLS IL6 TNF CELL DIFFERENTIATION ESCHERICHIA COLI IMMUNE RESPONSE INFLAMMATION ERBB-2 DIABETES MELLITUS AUTOPHAGY CELL PROLIFERATION IL23A PARKINSON DISEASE ALZHEIMER'S DISEASE IFNG SOD1 REMICADE AGING STREPTOCOCCUS PNEUMONIAE NEURODEGENERATIVE DISORDERS LISTERIA MONOCYTOGENES BREAST CANCER CELL DIVISION ANGIOGENESIS INSULIN CASP3 CELL DEATH STAPHYLOCOCCUS AUREUS TP53 HELICOBACTER PYLORI METFORMIN RHEUMATOID ARTHRITIS CTLA4 RECEPTOR FOXP3 CANDIDA ALBICANS 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE APOPTOTIC PROCESS PORPHYROMONAS GINGIVALIS PSEUDOMONAS AERUGINOSA IL17A CD4

© 2019 Biovista Vizit All Rights Reserved.